BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 1222886)

  • 1. A multicenter double blind clinical trial on 3.4.5-trimethoxybenzoiyl-epsilon-aminocaproic acid (C-3) in acute myocardial infarction.
    Rossi P; Brusca A; di Pretoro L; Fazzini PF; Galassi A; Gentile M; Gramolini C; Lombardi M; Lotto A; Martinelli A; Palma G; Poppi A; Porciello PI; Prati PL
    G Ital Cardiol; 1975; 5(6):914-22. PubMed ID: 1222886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Trial therapy with 3,4,5 trimethoxybenzoyl-epsilon-aminocaproic acid in acute myocardial infarct].
    Selvini A; Belli C; Corallo S; Gramolini C; Ferrari ML
    G Ital Cardiol; 1973 May; 3(5):661-73. PubMed ID: 4589173
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral captopril versus placebo among 14,962 patients with suspected acute myocardial infarction: a multicenter, randomized, double-blind, placebo controlled clinical trial. Chinese Cardiac Study (CCS-1) Collaborative Group.
    Chin Med J (Engl); 1997 Nov; 110(11):834-8. PubMed ID: 9772413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should patients in cardiogenic shock undergo rescue angioplasty after failed fibrinolysis: comparison of primary versus rescue angioplasty in cardiogenic shock patients.
    Kunadian B; Vijayalakshmi K; Dunning J; Thornley AR; Sutton AG; Muir DF; Wright RA; Hall JA; de Belder MA
    J Invasive Cardiol; 2007 May; 19(5):217-23. PubMed ID: 17476036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Usefulness and safety of intravenous thrombolytic therapy for elderly patients with acute myocardial infarction: relationship with cardiac rupture].
    Sakai M; Imai T; Kuboki K; Maeda S; Ueda S; Kuwajima I; Ohkawa S; Matsushita S
    J Cardiol; 1999 Mar; 33(3):153-61. PubMed ID: 10225195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of patients aged >or=75 years in the SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK (SHOCK) trial: do elderly patients with acute myocardial infarction complicated by cardiogenic shock respond differently to emergent revascularization?
    Dzavik V; Sleeper LA; Picard MH; Sanborn TA; Lowe AM; Gin K; Saucedo J; Webb JG; Menon V; Slater JN; Hochman JS;
    Am Heart J; 2005 Jun; 149(6):1128-34. PubMed ID: 15976798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical features and treatment of cardiogenic shock complicated with acute myocardial infarction].
    Zhao YS; Wang SW; Lu CY; Wu XL; Li YF; Liu LL; Yan MY; Cheng R
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Mar; 16(3):148-50. PubMed ID: 15009960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Short and intermediate term clinical outcome in patients with cardiogenic shock treated with aortic counterpulsation].
    Fornaro G; Prando MD; Parodi F; Cordero G; Sansa M; Bongo AS; Campi A; Aralda D; Dellavesa P; Aina F; Lazzero M; Cernigliaro C
    G Ital Cardiol; 1996 Dec; 26(12):1385-99. PubMed ID: 9162668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Impact of the intra-aortic balloon pump in the mortality due to cardiogenic shock secondary to acute myocardial infarction].
    Arias EA; González-Chon O; García-López SM; Chacón MA; Noriega-Iriondo F; Vega RE; Chávez-Tapia NC
    Arch Cardiol Mex; 2005; 75(3):260-6. PubMed ID: 16294814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary angioplasty for cardiogenic shock complicating acute myocardial infarction.
    Calton R; Jaison TM; David T
    Indian Heart J; 1999; 51(1):47-54. PubMed ID: 10327779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intramuscular injection of lidocaine in prevention of complications and mortality in acute myocardial infarction: double blind study on 246 cases (author's transl)].
    Rossi P; Lombardi M; Lotto A; Puddu V
    G Ital Cardiol; 1976; 6(2):220-4. PubMed ID: 795696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial and ethnic differences in the treatment and outcome of cardiogenic shock following acute myocardial infarction.
    Palmeri ST; Lowe AM; Sleeper LA; Saucedo JF; Desvigne-Nickens P; Hochman JS;
    Am J Cardiol; 2005 Oct; 96(8):1042-9. PubMed ID: 16214435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study Group.
    Breddin K; Loew D; Lechner K; Oberla K; Walter E
    Circulation; 1980 Dec; 62(6 Pt 2):V63-72. PubMed ID: 6777073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interhospital transfer for early revascularization in patients with ST-elevation myocardial infarction complicated by cardiogenic shock--a report from the SHould we revascularize Occluded Coronaries for cardiogenic shocK? (SHOCK) trial and registry.
    Jeger RV; Tseng CH; Hochman JS; Bates ER
    Am Heart J; 2006 Oct; 152(4):686-92. PubMed ID: 16996836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylprednisolone as an intervention following myocardial infarction. The Solu-Medrol Sterile Powder AMI Studies Group.
    J Int Med Res; 1986; 14 Suppl 1():1-10. PubMed ID: 2875003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing practice patterns in the management of acute myocardial infarction complicated by cardiogenic shock: elderly compared with younger patients.
    Dzavík V; Burton JR; Kee C; Teo KK; Ignaszewski A; Lucas AR; Tymchak WJ
    Can J Cardiol; 1998 Jul; 14(7):923-30. PubMed ID: 9706277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute myocardial infarction in the elderly--the differences compared with the young.
    Woon VC; Lim KH
    Singapore Med J; 2003 Aug; 44(8):414-8. PubMed ID: 14700421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term mortality in patients with myocardial infarction: impact of early treatment with captopril for 4 weeks.
    Liu L;
    Chin Med J (Engl); 2001 Feb; 114(2):115-8. PubMed ID: 11780187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ulterior observations on the use of C3 in acute myocardial infarction: 105 patients were treated within the 1st 6 hours after the symptoms started].
    Selvini A; Belli C; Corallo S; Gramolini C
    Arch Inst Cardiol Mex; 1976; 46(2):222-31. PubMed ID: 938161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery.
    Katz JN; Stebbins AL; Alexander JH; Reynolds HR; Pieper KS; Ruzyllo W; Werdan K; Geppert A; Dzavik V; Van de Werf F; Hochman JS;
    Am Heart J; 2009 Oct; 158(4):680-7. PubMed ID: 19781431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.